Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.

El-Sadr, W M; Grund, B; Neuhaus, J; Babiker, A; Cohen, C J; Darbyshire, J; Emery, S; Lundgren, J D; Phillips, A; Neaton, J D

El-Sadr, W M; Grund, B; Neuhaus, J; Babiker, A; Cohen, C J; Darbyshire, J; Emery, S; Lundgren, J D; Phillips, A; Neaton, J D.

Ann Intern Med ; 149(5): 289-99, 2008 Sep 02.

Article in En | MEDLINE | ID: mdl-18765698

Subject(s)

AIDS-Related Opportunistic Infections/etiology; Anti-HIV Agents/administration & dosage; HIV Infections/drug therapy; CD4 Lymphocyte Count; Drug Administration Schedule; Follow-Up Studies; HIV/genetics; HIV Infections/immunology; HIV Infections/virology; Humans; Kaplan-Meier Estimate; RNA, Viral/blood; Risk Factors; Viral Load

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 / 4_TD Database: MEDLINE Main subject: HIV Infections / AIDS-Related Opportunistic Infections / Anti-HIV Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Intern Med Year: 2008 Document type: Article

Search on Google

XML

PubMed Links